Retatrutide (10mg)

The World's Most Talked-About Weight Loss Compound

Retatrutide is generating extraordinary excitement in metabolic research — and for good reason. As the world's first triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, it works on three powerful fat-burning and appetite-suppressing pathways at once, making it the most advanced compound of its kind currently under investigation.

What the Research Shows

Phase 2 clinical trials have reported some of the most impressive body weight reduction results ever recorded — with participants losing up to 24% of body weight over 48 weeks. These results have far exceeded those seen with existing GLP-1 compounds and have positioned retatrutide as one of the most talked-about molecules in weight management research worldwide.

Key Research Areas

• Significant and sustained body weight reduction
• Appetite suppression and food intake regulation
• Improved metabolic markers and blood glucose control
• Energy balance and fat oxidation

Supplied as lyophilized powder at ≥99% purity, verified by HPLC and mass spectrometry. 10mg per vial.

⚠ For in-vitro research and laboratory use only. Not for human consumption.